ESC 365 - Managing patients in secondary prevention according to the 2021 ESC guidelines.

EAPC Premium Access

Managing patients in secondary prevention according to the 2021 ESC guidelines.

Session: Managing atherosclerotic cardiovascular disease (ASCVD) patients: polypill strategy as baseline treatment

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor B. Weisser (Kiel, DE)

Sponsored by Ferrer

Event: ESC Preventive Cardiology 2022

Congress Presentation

About the speaker

Professor Burkhard Weisser

Christian-Albrechts-University Kiel, Kiel (Germany)

2 presentations

0 follower

2 more presentations in this session

Reduction in recurrent MACE in patients with CHD. Results of the Neptuno substudy.

Speaker: Doctor R. Dalmau (Madrid, ES)

Q&A and closing.

Speaker: Professor B. Weisser (Kiel, DE) Doctor R. Dalmau (Madrid, ES)

Access the full session

Managing atherosclerotic cardiovascular disease (ASCVD) patients: polypill strategy as baseline treatment

Speakers: Professor B. Weisser, Doctor R. Dalmau, Professor B. Weisser, Doctor R. Dalmau

About the event

ESC Preventive Cardiology 2022

7 April - 9 April 2022

Sessions Presentations

Congress

Related content

Open Access

Real-world evidence with the ARBs and conclusions.

27 August 2021

ESC Premium Access

When is secondary mitral regurgitation severe?

27 August 2021

ESC Premium Access

A practical approach to the patient with claudication: how I did treat.

27 August 2021

ESC 365 is supported by